• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨质疏松症作为泰国痴呆症潜在的可改变风险因素:一项横断面分析。

Osteoporosis as a Potential Modifiable Risk Factor for Dementia in Thailand: A Cross-Sectional Analysis.

作者信息

Hiri-O-Tappa Parit, Lawongsa Kasidid, Kengpanich Supatcha, Srisuwan Patsri

机构信息

Family Medicine, Phramongkutklao Hospital, Bangkok, THA.

Geriatrics, Phramongkutklao Hospital, Bangkok, THA.

出版信息

Cureus. 2024 Jun 30;16(6):e63511. doi: 10.7759/cureus.63511. eCollection 2024 Jun.

DOI:10.7759/cureus.63511
PMID:39081449
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11288215/
Abstract

OBJECTIVE

This study aims to explore the potential of osteoporosis as a modifiable risk factor for dementia and investigate whether treatments like estrogen supplementation and bisphosphonates can reduce the risk of dementia in the Thai population. This study aimed to evaluate the risk of dementia in patients with osteoporosis.

MATERIALS AND METHODS

A cross-sectional analysis was conducted. Participants aged <50 years and those with a history of dementia at baseline were excluded. Clinical variables were analyzed using the chi-squared test. Logistic regression analysis was conducted to determine independent factors of dementia after adjusting for potential confounders.

RESULTS

The cohort was conducted on 54,399 participants, of whom 9763 (17.9%) had osteoporosis. The results indicated that individuals with osteoporosis had an odds ratio (OR) of 1.62-fold higher risk of developing dementia compared to those without osteoporosis (95% confidence interval (CI) 1.37-1.92, p-value < 0.001). Furthermore, compared to patients with osteoporosis not undergoing any treatment, those receiving estrogen supplementation and bisphosphonate treatment showed reduced associations with dementia, with an OR of 0.84 (95% CI 0.73-0.98, p-value = 0.023) and 0.66 (95% CI 0.60-0.73, p-value < 0.001), respectively.

CONCLUSION

The study findings suggest an elevated risk of dementia in patients with osteoporosis and contribute substantially to our understanding of the link between osteoporosis and dementia in the Thai population.

摘要

目的

本研究旨在探讨骨质疏松症作为痴呆症可改变风险因素的可能性,并调查雌激素补充剂和双膦酸盐等治疗方法是否能降低泰国人群患痴呆症的风险。本研究旨在评估骨质疏松症患者患痴呆症的风险。

材料与方法

进行横断面分析。排除年龄小于50岁的参与者以及基线时有痴呆症病史的参与者。使用卡方检验分析临床变量。进行逻辑回归分析以确定在调整潜在混杂因素后痴呆症的独立因素。

结果

该队列研究共纳入54399名参与者,其中9763人(17.9%)患有骨质疏松症。结果表明,与未患骨质疏松症的人相比,患有骨质疏松症的人患痴呆症的风险高出1.62倍(95%置信区间(CI)为1.37 - 1.92,p值<0.001)。此外,与未接受任何治疗的骨质疏松症患者相比,接受雌激素补充剂和双膦酸盐治疗的患者与痴呆症的关联降低,其比值比(OR)分别为0.84(95% CI 0.73 - 0.98,p值 = 0.023)和0.66(95% CI 0.60 - 0.73,p值<0.001)。

结论

研究结果表明骨质疏松症患者患痴呆症的风险升高,并极大地有助于我们理解泰国人群中骨质疏松症与痴呆症之间的联系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/11288215/ecc59985551e/cureus-0016-00000063511-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/11288215/ecc59985551e/cureus-0016-00000063511-i01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7cc/11288215/ecc59985551e/cureus-0016-00000063511-i01.jpg

相似文献

1
Osteoporosis as a Potential Modifiable Risk Factor for Dementia in Thailand: A Cross-Sectional Analysis.骨质疏松症作为泰国痴呆症潜在的可改变风险因素:一项横断面分析。
Cureus. 2024 Jun 30;16(6):e63511. doi: 10.7759/cureus.63511. eCollection 2024 Jun.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Increased risk of dementia in patients with osteoporosis: a population-based retrospective cohort analysis.骨质疏松症患者患痴呆症风险增加:一项基于人群的回顾性队列分析。
Age (Dordr). 2014 Apr;36(2):967-75. doi: 10.1007/s11357-013-9608-x. Epub 2013 Dec 18.
4
Association of Dementia Risk With Focal Epilepsy and Modifiable Cardiovascular Risk Factors.痴呆风险与局灶性癫痫和可改变的心血管危险因素的关联。
JAMA Neurol. 2023 May 1;80(5):445-454. doi: 10.1001/jamaneurol.2023.0339.
5
Mild cognitive impairment in a Spanish representative sample: prevalence and associated factors.西班牙代表性样本中的轻度认知障碍:患病率及相关因素
Int J Geriatr Psychiatry. 2016 Aug;31(8):858-67. doi: 10.1002/gps.4398. Epub 2016 Feb 28.
6
Osteonecrosis of the jaw in older osteoporosis patients treated with intravenous bisphosphonates.静脉用双膦酸盐治疗的老年骨质疏松症患者的颌骨坏死。
Ann Pharmacother. 2011 Oct;45(10):1199-206. doi: 10.1345/aph.1Q239. Epub 2011 Sep 27.
7
Strength together: examining risk and protective factors associated with dementia and cognitive impairment in Aboriginal and Torres Strait Islander peoples through harmonisation of landmark studies.携手共进:通过整合标志性研究,探究与澳式原住民和托雷斯海峡岛民痴呆症和认知障碍相关的风险和保护因素。
BMC Neurol. 2024 Jun 1;24(1):185. doi: 10.1186/s12883-024-03688-y.
8
Cognitive Impairment in Thalassemia and Associated Factors.地中海贫血相关认知障碍及影响因素。
Dement Geriatr Cogn Disord. 2022;51(2):128-134. doi: 10.1159/000522655. Epub 2022 Mar 23.
9
Treatment for osteoporosis in people with ß-thalassaemia.β地中海贫血患者骨质疏松症的治疗
Cochrane Database Syst Rev. 2016 Mar 10;3:CD010429. doi: 10.1002/14651858.CD010429.pub2.
10
Association between dementia parental family history and mid-life modifiable risk factors for dementia: a cross-sectional study using propensity score matching within the Lifelines cohort.痴呆症父母家族史与中年可改变的痴呆症风险因素之间的关联:使用 Lifelines 队列内倾向评分匹配的横断面研究。
BMJ Open. 2021 Dec 20;11(12):e049918. doi: 10.1136/bmjopen-2021-049918.

本文引用的文献

1
From the Mind to the Spine: The Intersecting World of Alzheimer's and Osteoporosis.从大脑到脊柱:阿尔茨海默病与骨质疏松症的交叉领域
Curr Osteoporos Rep. 2024 Feb;22(1):152-164. doi: 10.1007/s11914-023-00848-w. Epub 2024 Feb 9.
2
Dementia, osteoporosis and fragility fractures: Intricate epidemiological relationships, plausible biological connections, and twisted clinical practices.痴呆、骨质疏松症和脆性骨折:复杂的流行病学关系、合理的生物学联系和扭曲的临床实践。
Ageing Res Rev. 2024 Jan;93:102130. doi: 10.1016/j.arr.2023.102130. Epub 2023 Nov 27.
3
Common Signaling Pathways Involved in Alzheimer's Disease and Stroke: Two Faces of the Same Coin.
阿尔茨海默病和中风中涉及的常见信号通路:同一硬币的两面。
J Alzheimers Dis Rep. 2023 May 12;7(1):381-398. doi: 10.3233/ADR-220108. eCollection 2023.
4
Association of Bone Mineral Density and Dementia: The Rotterdam Study.骨密度与痴呆的相关性研究:鹿特丹研究。
Neurology. 2023 May 16;100(20):e2125-e2133. doi: 10.1212/WNL.0000000000207220. Epub 2023 Mar 22.
5
Osteoporosis and Dementia: Establishing a Link.骨质疏松症与痴呆症:建立联系
J Bone Miner Res. 2021 Nov;36(11):2103-2105. doi: 10.1002/jbmr.4431. Epub 2021 Sep 19.
6
Prevalence of treatable and reversible dementias: A study in a dementia outpatient clinic.可治疗和可逆性痴呆的患病率:在一家痴呆门诊诊所进行的一项研究。
Dement Neuropsychol. 2011 Jan-Mar;5(1):44-47. doi: 10.1590/S1980-57642011DN05010008.
7
Vitamin D and the risk of dementia and Alzheimer disease.维生素 D 与痴呆症和阿尔茨海默病的风险。
Neurology. 2014 Sep 2;83(10):920-8. doi: 10.1212/WNL.0000000000000755. Epub 2014 Aug 6.
8
Increased risk of dementia in patients with osteoporosis: a population-based retrospective cohort analysis.骨质疏松症患者患痴呆症风险增加:一项基于人群的回顾性队列分析。
Age (Dordr). 2014 Apr;36(2):967-75. doi: 10.1007/s11357-013-9608-x. Epub 2013 Dec 18.
9
The epidemiology of Alzheimer's disease: laying the foundation for drug design, conduct, and analysis of clinical trials.阿尔茨海默病的流行病学:为药物设计、临床试验的实施和分析奠定基础。
Alzheimers Dement. 2012 May;8(3):237-42. doi: 10.1016/j.jalz.2011.12.005.
10
Undertreatment of osteoporosis in persons with dementia? A population-based study.痴呆患者骨质疏松症治疗不足?一项基于人群的研究。
Osteoporos Int. 2012 Mar;23(3):1061-8. doi: 10.1007/s00198-011-1636-8. Epub 2011 Apr 16.